ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

VAL Valirx Plc

3.45
0.00 (0.00%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Valirx Plc LSE:VAL London Ordinary Share GB00BLH13C52 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.45 3.40 3.50 3.45 3.45 3.45 1,232,579 07:31:42
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 0 -2.37M -0.0262 -1.32 3.11M
Valirx Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker VAL. The last closing price for Valirx was 3.45p. Over the last year, Valirx shares have traded in a share price range of 3.45p to 14.75p.

Valirx currently has 90,174,156 shares in issue. The market capitalisation of Valirx is £3.11 million. Valirx has a price to earnings ratio (PE ratio) of -1.32.

Valirx Share Discussion Threads

Showing 26701 to 26721 of 29350 messages
Chat Pages: Latest  1078  1077  1076  1075  1074  1073  1072  1071  1070  1069  1068  1067  Older
DateSubjectAuthorDiscuss
16/5/2023
13:29
The video presentation by professor Martin ulmschneider on CLX001 tbc at Cytolytix


The comparison with the current medication Cisplatin for breast cancer was amazing considering no toxicity for CLX001
My fiancée had cancer and used Cisplatin and her side effects were horrendous.
She is a reflexology specialist and bio resonance practitioner and said a lot of her clients are in remission and have used the current standard care and there is definitely a space for CLX001 in the pharma market.

jasonpugh
14/5/2023
22:23
Porky9 pay no attention to Jasonpugh he is an out and out liar!
pinkpudycat
14/5/2023
19:26
@JasonPugh
Previously I gave you time of day. Also due to the fact you have ADHD and I have a son with Dyspraxia I was more so tolerant as I recognised that with a spectrum disorder you are more likely to over analyse and view things from a black and white perspective, no grey areas, so I totally get that.

However, what you have taught me is due to your actions, some of which being dam snake like and nasty is that you can have ADHD and still be a C U Next Tuesday. The two conditions are not mutually exclusive.

Do what you like, not interested.

porky9
14/5/2023
12:45
@porky. Financial advice for you free of charge. Sell your 200,000 shares for £20k. 10pps. Then buy back on your own share price prediction of 5pps and double your share count 400,000 for same amount of cash. If you dont sell now according to your own financial advice how are fellow investors going to view your strategy?
jasonpugh
14/5/2023
08:03
It was something on the chat that was reportedly said on the telegram group just before suzy dropped the 10p placing bomb. Remember slater started selling just before 🧐. Could be wrong but this time slater is very happy with his £1 target price. Something has changed obviously. DYOR
jasonpugh
14/5/2023
06:02
Jason, can you expand on this? Offer of what please? Takeover?
wulber
13/5/2023
23:52
Adam and slater were given an offer of 15pps before 10p placing. It appears they could have possibly been offered another financial incentive ( will become common knowledge soon obviously if true). This is borne out by slaters excitement just recently with his recent comments. Adams silence is interesting. So easy to read. Await counter argument
jasonpugh
13/5/2023
01:13
@porky. Sell your 200,000 for £20k (10pps)
When it hits your 5p target you can buy 400,000 for the same equity.
Question. Why do you still hold if you say it will be 5p? Are you willing to lose 10 grand on principle.

jasonpugh
11/5/2023
22:11
The thing is Porky Pie, nobody believes you because you have other motives and some things you say are correct to provide doubt and maybe stupid people would believe you but l have to give credit to most posters as they have half a sense of intelligence so when you post here or on LSE they simply roll their eyes. please stop as your embarrassing yourself now.Go back to the day job please and leave me to retire with my pot l have made on LSE and others that actually want proper stock conversation. thank you.
wulber
11/5/2023
22:01
Lets see the forward plans from H2 but currently not impressed.Hahahha - so sell 200,000 shares then you have and buy back cheaper?
wulber
11/5/2023
21:59
Regarding the lab, read the CENKOS report, it is to focus on own pipeline products first and not expected to deliver any revenues until 2024. Whilst the lab is a great addition for the long term and will take time and more working capital to reach breakeven this wasn't why investors invested here, they are supporting a lab start up business now by default. > LOL, that is not how it readsFinally, They currently need circa £2.5m of capital for one years cash burn based on the current business plan and will need more than that IF they continue with the current BUY and BUILD policy.> that is allBSLets see the forward plans from H2 but currently not impressed.
wulber
11/5/2023
21:57
WulberIf THX couldn't secure funding during the boom, what chance have they now in a biotech funding drought?> what boom? Just came out of Covid and then the Ukraine situation!What proof or otherwise have you actually seen? Why is the board not sharing that proof if it actually exists at this stage? THX have not delivered on any set deadline and in response to that, rather than tie them down or remove exclusivity to talk to other parties, VAL have simply removed any timelines and now we are nearly two years on. Great.> What proof have you seen to the contrary?Do you not realise that there NDA's in place if you know what that is?Regarding the lab, read the CENKOS report, it is to focus on own pipeline products first and not expected to deliver any revenues until 2024. Whilst the lab is a great addition for the long term and will take time and more working capital to reach breakeven this wasn't why investors invested here, they are supporting a lab start up business now by default.Finally, They currently need circa £2.5m of capital for one years cash burn based on the current business plan and will need more than that IF they continue with the current BUY and BUILD policy.Lets see the forward plans from H2 but currently not impressed.
wulber
11/5/2023
18:41
@Wulber
If THX couldn't secure funding during the boom, what chance have they now in a biotech funding drought?

What proof or otherwise have you actually seen? Why is the board not sharing that proof if it actually exists at this stage? THX have not delivered on any set deadline and in response to that, rather than tie them down or remove exclusivity to talk to other parties, VAL have simply removed any timelines and now we are nearly two years on. Great.

Regarding the lab, read the CENKOS report, it is to focus on own pipeline products first and not expected to deliver any revenues until 2024. Whilst the lab is a great addition for the long term and will take time and more working capital to reach breakeven this wasn't why investors invested here, they are supporting a lab start up business now by default.

Finally, They currently need circa £2.5m of capital for one years cash burn based on the current business plan and will need more than that IF they continue with the current BUY and BUILD policy.

Lets see the forward plans from H2 but currently not impressed.

porky9
11/5/2023
18:24
Because the BOD have treated shareholders with utter contempt. Kept shareholders in the dark, constantly missed deadlines, made numerous errors and shown no sign of learning from those errors and even now, nearly two years on in relation to the LOI and exclusive agreed with THX in respect of 201 have not given any proper clarity.

201 should be out on the next stage trials, not still waiting for some two bit US start up to see if it can get funded or not two years later. I am actually deeply upset that 201 is not on trials currently. What good is it doing anyone because the BOD don't have the business acumen or backbone to sort it and are still even now, letting it drift?

As for seeing shareholders suffering, if you were one of the lucky ones in at 3.5p or traders that got in and out at the right times, good profits were bagged, but if you are an unlucky long term holder you have been constantly diluted from numerous raise/spend/consolidate cycles with no sign of that stopping anytime soon.

Currently, posters like you have been pumping this to try and encourage uninformed newbies to buy in knowing full well as made clear by the board and the report issued by CENKOS that they will need to raise more capital to meet the current business plan objectives. It is unfair of you at this stage to try and encourage newbies to buy in knowing they will be diluted. You are not nice.

Frankly, you need Adam to take control, clear out the dead wood and guide this business forward to success. Appoint board members that a) have experience of negotiating deals b) will actually BUY shares and lead by example c) focus on what is important NOT dreaming of acquisitions they can make with other peoples money they don't have. Buy and build plans = ridiculous, prove current concept first.

I await the AGM and the forward plans from H2, I would back this business A) if Adam was directing it and made the changes required and B) the forthcoming sixth raise was going to be the last to get the labs to break even so they are self sufficient. As it stands, its currently totally uninvestable IMO.

Lets see how events unfold

porky9
11/5/2023
18:17
Give it a rest Porky
wulber
11/5/2023
14:51
I've not bought a share for many months which I'm happy to prove to anyone So yet again you are wrong I will not sell any more Val either ,not in the teens anyway.You keep saying by June but you are a year out For someone who isn't a buyer why the hell do you slate this share ? Oh cos you want to see holders lose money and patients suffer ..not nice are you porky .
nico115
11/5/2023
10:09
Totally agree. Porky is very influential and consistently sophisticated in his/her misleading comments and relentless (2am posts😂) Take professor Martin ulmschneider comments on the Cytolytix video. If it was not for me highlighting porkys deliberate mis quoting him people would be taken in.
He/she does get good marks for working out but the rest leaves a lot to be desired.
Ps. I personally think porky would make a fantastic Attorney in usa. Very rigorous and would fit in perfectly. A complementary comment. ❤️ 8076;

jasonpugh
11/5/2023
09:46
"current eye watering 10m valuation"Haha for 301 201 401 kings and a lab That's wrong mkt cap Without lab and kings you thought mkt cap of £50m was way too cheap You are a desperate buyer porky Shame you are going to miss out mate .Less intransigence my friend : )
nico115
11/5/2023
07:00
2am porky. As a student you will be punctual at least. Letts education do a gcse on buisness. We can start there if you like. Ps. If you dont mind. Would it be possible to use your dddd investment as a test case for other students in NOT what to do? 👍
jasonpugh
11/5/2023
06:42
2.01am Porky! Can't sleep?
wulber
11/5/2023
02:01
@Wulber
Let’s see what lands first then shall we
A commercial deal with cash on the table north of £2.5m to cover a years funding OR a discounted placing on VALs current eye watering 10m valuation. Answers on a postcard.

They have given our prize asset 201 to a start up for £1.3m down which still hasn’t completed in nearly two years and now all of a sudden they are going to negotiate a real deal and get some cash in on a pre-clinical asset?

So far they have proven they can’t negotiate their way out of a paper bag.

@Jasonpugh
And you are about to learn a lesson that there is no such thing as a certain bet when it comes to penny shares. This one is a veteran when it comes to raise/spend/consolidate and you will soon see it in action. It is on AIM to raise cash for a reason.

15 years no revenue, 3 shares consolidations, five raises since Suzy took over and about to see a sixth. Follow the BOD, they are not buying for a reason, follow what they do. Buy when Stella buys.

Meanwhile results statement illustrating the increased cash burn due any moment.Good luck with that.

porky9
Chat Pages: Latest  1078  1077  1076  1075  1074  1073  1072  1071  1070  1069  1068  1067  Older

Your Recent History

Delayed Upgrade Clock